Legato Merger Corp III LEGT Q1 2026 Earnings Minimal Activity as SPAC Holds Cash Reports Positive EPS NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase AAUC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surges Past Expectations by 315 Stock Edges Lower PEBK Q4 2025 Earnings Strong EPS Performance Amid Quiet Trading INSE Q1 2026 Earnings NarrowerThanExpected Loss Boosts Sentiment Despite Revenue Uncertainty